Refractory depression – cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial

ro_dbtpapertier 3link ok

Open source

ID
88133491bd7c48ea
Source org
PubMed Central
Author
Published
OA status
DOI
10.1192/bjo.2019.57
PMID
PMCID
PMC6669879
Citations

Tags

Verification

Automated checks only — not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:88133491bd7c48ea,
  title = {Refractory depression – cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial},
  journal = {PubMed Central},
  doi = {10.1192/bjo.2019.57},
  url = {https://doi.org/10.1192/bjo.2019.57}
}

RIS

TY  - JOUR
TI  - Refractory depression – cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial
PB  - PubMed Central
DO  - 10.1192/bjo.2019.57
UR  - https://doi.org/10.1192/bjo.2019.57
ER  - 

APA

Refractory depression – cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial. (n.d.). PubMed Central. https://doi.org/10.1192/bjo.2019.57

Related entries